Essentially, forcing cancer cells to experience hypermalonylation (either by SIRT5 inhibition or malonyl-CoA accumulation) can tip their finely tuned metabolism into dysfunction, leading to growth arrest or cell death. This evidence concerns the gene SIRT5 and cancer.